PAPER Cheng X, Yang L, He P, Li R, Shen Y
SEARCH RESULTS
331061 RESULTS
PAPER Ciaramella A, Bizzoni F, Salani F, Vanni D, Spalletta G, Sanarico N, Vendetti S, Caltagirone C, Bossù P
Increased Pro-Inflammatory Response by Dendritic Cells from Patients with Alzheimer's Disease.
J Alzheimers Dis. 2009 Nov 5; PubMed: 19893175PAPER Reitz C, Mayeux R
Use of Genetic Variation as Biomarkers for Mild Cognitive Impairment and Progression of Mild Cognitive Impairment to Dementia.
J Alzheimers Dis. 2009 Nov 5; PubMed: 19893176PAPER Lynn BC, Wang J, Markesbery WR, Lovell MA
Quantitative Changes in the Mitochondrial Proteome from Subjects with Mild Cognitive Impairment, Early Stage, and Late Stage Alzheimer's Disease.
J Alzheimers Dis. 2009 Nov 5; PubMed: 19893178PAPER Cheng X, Yang L, He P, Li R, Shen Y
Differential Activation of Tumor Necrosis Factor Receptors Distinguishes between Brains from Alzheimer's Disease and Non-Demented Patients.
J Alzheimers Dis. 2009 Nov 5; PubMed: 19893179PAPER Politis A, Olgiati P, Malitas P, Albani D, Signorini A, Polito L, De Mauro S, Zisaki A, Piperi C, Stamouli E, Mailis A, Batelli S, Forloni G, De Ronchi D, Kalofoutis A, Liappas I, Serretti A
Vitamin B12 Levels in Alzheimer's Disease: Association with Clinical Features and Cytokine Production.
J Alzheimers Dis. 2009 Nov 5; PubMed: 19893180PAPER Cardoso S, Correia S, Santos RX, Carvalho C, Santos MS, Oliveira CR, Perry G, Smith MA, Zhu X, Moreira PI
Insulin is a Two-Edged Knife on the Brain.
J Alzheimers Dis. 2009;18(3):483-507. PubMed: 19893181PAPER Calkins MP
Evidence-based long term care design.
NeuroRehabilitation. 2009;25(3):145-54. PubMed: 19893184PAPER Lockhart IA, Mitchell SA, Kelly S
Safety and tolerability of donepezil, rivastigmine and galantamine for patients with Alzheimer's disease: systematic review of the 'real-world' evidence.
Dement Geriatr Cogn Disord. 2009;28(5):389-403. PubMed: 19893314PAPER Delis DC, Fine EM, Stricker JL, Houston WS, Wetter SR, Cobell K, Jacobson MW, Salmon DP, Bondi MW
Comparison of the traditional recall-based versus a new list-based method for computing semantic clustering on the California Verbal Learning Test: evidence from Alzheimer's disease.
Clin Neuropsychol. 2010 Jan;24(1):70-9. PubMed: 19894184PAPER Kichev A, Ilieva EV, Piñol-Ripoll G, Podlesniy P, Ferrer I, Portero-Otín M, Pamplona R, Espinet C
Cell death and learning impairment in mice caused by in vitro modified pro-NGF can be related to its increased oxidative modifications in Alzheimer disease.
Am J Pathol. 2009 Dec;175(6):2574-85. PubMed: 19893045PAPER Plaschke K, Kopitz J, Siegelin M, Schliebs R, Salkovic-Petrisic M, Riederer P, Hoyer S
Insulin-Resistant Brain State after Intracerebroventricular Streptozotocin Injection Deteriorates Alzheimer-like Changes in Tg2576 AbetaPP-Overexpressing Mice.
J Alzheimers Dis. 2009 Nov 5; PubMed: 19893161PAPER Hernandez S, McClendon MJ, Zhou XH, Sachs M, Lerner AJ
Pharmacological Treatment of Alzheimer's Disease: Effect of Race and Demographic Variables.
J Alzheimers Dis. 2009 Nov 5; PubMed: 19893167PAPER Landhuis E, Dance A
Alzforum News Highlights: Caffeine, Anesthesia, and Twin Epigenetics.
J Alzheimers Dis. 2009 Nov 5; PubMed: 19893177Akt1
ANTIBODY polyclonal manufacturer Cat# LS-C52597 Immunogen = synthetic peptide corresp. to a region of human AKT1 liquid, PBS, sucrose, affinity purified Akt1 IgG Akt and Serine/Threonine Kinases LifeSpan Biosciences, Inc. Rabbit Dog Human Mouse Akt1 http://alzforu
Current Filters
No filters selected